The short answer
An ALK rearrangement is a biomarker result. It means a gene rearrangement involving ALK. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.
An ALK rearrangement is a biomarker or molecular result, not a treatment decision by itself.
It can be relevant in some lung cancers and certain rare tumors.
A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.
Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.
Choose how you want to understand this
The full explanation.
The short answer
An ALK rearrangement means two pieces of DNA have joined together in the cancer cells. This makes the ALK gene produce an abnormal protein. That protein tells the cancer to keep growing. Doctors find this by testing the tumor, or sometimes a blood sample. It shows up most often in non-small cell lung cancer. It is a change that arose in the cancer cells — not something you inherited.
Where it may be relevant
This result can be relevant in some lung cancers, and in certain rare tumors. Not everyone with these cancers needs, or benefits from, the same testing or treatment.
Why it can affect treatment options
ALK-rearranged lung cancer usually responds well to a class of pills called ALK inhibitors. These include alectinib, brigatinib, and lorlatinib. These drugs are often the first treatment used once the cancer has spread. Alectinib is also approved after surgery, specifically to lower the chance the cancer comes back. Many people take an ALK inhibitor for a long stretch of time before the cancer adapts and starts growing again. When that happens, other ALK inhibitors are often still available to try next.
One thing is worth knowing clearly: the first-line immunotherapy approvals in advanced non-small cell lung cancer are written for people who do not have an ALK alteration. NCI's PDQ summary notes that people with ALK or EGFR changes should have disease progression on an FDA-approved targeted therapy before receiving pembrolizumab. So a high PD-L1 score does not by itself move immunotherapy to the front of the line here. Your team can explain which specific option fits your situation.
What this result does NOT tell you
An ALK rearrangement does not guarantee a given ALK inhibitor will keep working indefinitely. Nearly all ALK-rearranged cancers eventually develop resistance to a specific drug, which is why several ALK inhibitors exist in sequence rather than just one. This result also does not tell you how advanced your cancer is — it describes a driver of growth, not a stage. And it does not mean immunotherapy is off the table forever; it means immunotherapy alone is usually not the first choice.
Is this urgent?
An ALK result is not itself an emergency, but it commonly changes the first treatment choice for advanced lung cancer, so it is usually acted on before systemic treatment begins.
Questions to ask
Ask whether your ALK rearrangement was confirmed by tumor tissue or blood testing. Ask which ALK inhibitor is being recommended first, and why. Ask what the plan is if the cancer starts growing again on that drug. Ask why immunotherapy is, or is not, part of your current plan.
Sources
Words to know
Tap any term to see what it means.
Common questions
What is an ALK rearrangement?
An ALK rearrangement means a gene rearrangement involving ALK. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.
Can it affect treatment?
Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.
What should I ask my oncologist?
Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up more plain-language explanations for report wording.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-17Next planned review: 2027-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share